GB:COIL Stock Latest News
Company AnnouncementsCoiled Therapeutics to Brief Investors on Progress of Lead Cancer Drug AO-2521M ago
Company AnnouncementsCoiled Therapeutics to Spotlight Precision Oncology Pipeline at Small Cap Showcase1M ago
Company AnnouncementsCoiled Therapeutics Director Increases Stake as Precision Oncology Pipeline Advances1M ago
Company AnnouncementsCoiled Therapeutics Advances Lead TACC3 Inhibitor AO-252 After AIM Transition and £8.5m Raise1M ago
Company AnnouncementsCoiled Therapeutics Advances AO-252 Softgel Formulation With Early Cohort Enrolment1M ago
Company AnnouncementsCoiled Therapeutics adds joint broker as it advances precision oncology pipeline2M agoCompany AnnouncementsCoiled Therapeutics Shifts London Headquarters as Lead Cancer Drug Advances in Trials2M ago
Company AnnouncementsCoiled Therapeutics launches optimised AO-252 softgel in U.S. Phase I study3M ago
Company AnnouncementsCoiled Therapeutics Advances Next-Generation AO-252 Softgel Ahead of Dose Expansion3M ago- Company AnnouncementsCoiled Therapeutics Publishes Investor Presentation as Lead Cancer Drug Advances in Phase I4M ago
- Company AnnouncementsCoiled Therapeutics AGM Backs Strategy but Votes Down Director Reappointment4M ago
Company AnnouncementsCoiled Therapeutics Adds Veteran Biotech Dealmaker Craig Tooman to Board4M ago
Company AnnouncementsCoiled Therapeutics to Present Precision Oncology Pipeline at Investor Forum4M agoCompany AnnouncementsCoiled Therapeutics to showcase oncology pipeline at London investor forum4M ago
Company AnnouncementsCoiled Therapeutics Grants 6.2 Million Share Options to Strengthen Leadership Incentives4M ago
Company AnnouncementsCoiled Therapeutics Strengthens Clinical Leadership for AO-252 With New Advisory Board4M ago- Company AnnouncementsCoiled Therapeutics strengthens scientific leadership with TACC3 expert hire4M ago
- Company AnnouncementsCoiled Therapeutics Issues New Shares to Settle Liabilities and Support Clinical Progress5M ago
- Company AnnouncementsCoiled Therapeutics Calls AGM as Lead Cancer Drug Advances Through Early Trials5M ago
Company AnnouncementsCoiled Therapeutics Lists on U.S. OTCQB to Broaden Investor Base5M agoCompany AnnouncementsCoiled Therapeutics Showcases Lead Cancer Drug AO-252 at Endless Frontier Labs 20265M ago
Company AnnouncementsCoiled Therapeutics Adds Leading Oncologist to Board as It Advances Novel TACC3 Inhibitor5M ago
